Skip to content

Envoy Medical COCH ATM Program issuances

ATM Program issuances at other companies

XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$5.5M
Envoy Medical logo
Envoy MedicalCOCH
$1.68M+296%
Trilogy Metals logo
Trilogy MetalsTMQ
$1.16M-80.9%
Flanigan's Enterprises logo
Flanigan's EnterprisesBDL
$1M
American Coastal Insurance Corporation logo
American Coastal Insurance CorporationACIC
$38.19M0.0%
GTY
Getty RealtyGTY
$19.92M+80.9%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockConsiderationReceivedOnTransaction.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's atm program issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's ATM program issuances?
Envoy Medical (COCH) reported ATM program issuances of $1.68M in Q1 2024.
How has Envoy Medical's ATM program issuances changed year-over-year?
Envoy Medical's ATM program issuances increased by 296.0% year-over-year, from $425K to $1.68M.
What does ATM program issuances mean?
Represents the total cash or non-cash consideration received from the sale of equity securities through an At-The-Market (ATM) offering program. This metric tracks the capital raised by issuing shares directly into the market at prevailing prices, providing insight into the company's ability to access liquidity without a traditional underwritten offering.